Follow
Carlo Rinaldi
Carlo Rinaldi
Verified email at dpag.ox.ac.uk
Title
Cited by
Cited by
Year
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
C Rinaldi, MJA Wood
Nature Reviews Neurology 14 (1), 9-21, 2018
6422018
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
4142012
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study
H Jacobi, P Bauer, P Giunti, R Labrum, MG Sweeney, P Charles, A Duerr, ...
Neurology 77 (11), 1035-1041, 2011
2232011
Cowchock syndrome is associated with a mutation in apoptosis-inducing factor
C Rinaldi, C Grunseich, IF Sevrioukova, A Schindler, I Horkayne-Szakaly, ...
The American Journal of Human Genetics 91 (6), 1095-1102, 2012
1482012
Hereditary Spastic Paraplegia Type 43 (SPG43) is Caused by Mutation in C19orf12
G Landouré, PP Zhu, CM Lourenço, JO Johnson, C Toro, KV Bricceno, ...
Human mutation 34 (10), 1357-1360, 2013
982013
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing—remitting active multiple sclerosis patients: a longitudinal controlled trial of combination …
R Lanzillo, G Orefice, M Quarantelli, C Rinaldi, A Prinster, G Ventrella, ...
Multiple Sclerosis Journal 16 (4), 450-454, 2010
892010
Mutation in CPT1C associated with pure autosomal dominant spastic paraplegia
C Rinaldi, T Schmidt, AJ Situ, JO Johnson, PR Lee, K Chen, LC Bott, ...
JAMA neurology 72 (5), 561-570, 2015
822015
MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties
N Chopra, R Wang, B Maloney, K Nho, JS Beck, N Pourshafie, ...
Molecular psychiatry 26 (10), 5636-5657, 2021
722021
Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy
C Rinaldi, LC Bott, K Chen, GG Harmison, M Katsuno, G Sobue, ...
Molecular medicine 18, 1261-1268, 2012
722012
Individual versus group therapy for obesity: comparison of dropout rate and treatment outcome
A Minniti, L Bissoli, V Di Francesco, F Fantin, R Mandragona, M Olivieri, ...
Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity 12, 161-167, 2007
652007
Spinal and bulbar muscular atrophy: pathogenesis and clinical management
C Grunseich, C Rinaldi, KH Fischbeck
Oral diseases 20 (1), 6-9, 2014
632014
Beyond motor neurons: expanding the clinical spectrum in Kennedy’s disease
R Manzano, G Sorarú, C Grunseich, P Fratta, E Zuccaro, M Pennuto, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (8), 808-812, 2018
602018
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results
F Saccà, M Quarantelli, C Rinaldi, T Tucci, R Piro, G Perrotta, ...
Journal of neurology 259, 132-138, 2012
592012
A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy
LC Bott, NM Badders, K Chen, GG Harmison, E Bautista, CCY Shih, ...
Human Molecular Genetics 25 (10), 1979-1989, 2016
582016
A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy
RC Bott LC, Badders NM, Chen KL, Harmison GG, Bautista E, Shih CC, Katsuno M ...
Hum Mol Genet, 2016
582016
A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy.
RC Bott LC, Badders NM, Chen KL, Harmison GG, Bautista E, Shih CC, Katsuno M ...
Hum Mol Genet., 0
58*
Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients
C Grunseich, K Zukosky, IR Kats, L Ghosh, GG Harmison, LC Bott, ...
Neurobiology of disease 70, 12-20, 2014
572014
Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
V Lombardi, G Querin, OJ Ziff, L Zampedri, I Martinelli, C Heller, M Foiani, ...
Neurology 92 (11), e1205-e1211, 2019
552019
Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
C Grunseich, IR Kats, LC Bott, C Rinaldi, A Kokkinis, D Fox, K Chen, ...
Neuromuscular Disorders 24 (11), 978-981, 2014
552014
Clinical manifestations of intermediate allele carriers in Huntington disease
E Cubo, MA Ramos-Arroyo, S Martinez-Horta, A Martínez-Descalls, ...
Neurology 87 (6), 571-578, 2016
542016
The system can't perform the operation now. Try again later.
Articles 1–20